[Effect of a pepsin-inhibiting pentapeptide on the secretion of pepsin and hydrochloric acid in the stomach].
D000328:Adult; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004415:Dyspepsia / Q000188:drug therapy; D005750:Gastric Juice / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000494:pharmacology*; D010434:Pepsin A / Q000378:metabolism*; D010436:Pepstatins / Q000494:pharmacology* / Q000627:therapeutic use; D010919:Placebos; D012636:Secretory Rate / Q000187:drug effects; D013276:Stomach Ulcer / Q000188:drug therapy
D009842:Oligopeptides; D010436:Pepstatins; D010919:Placebos; D010434:Pepsin A
Virkningen af et pepsinhaemmende pentapeptid på ventriklens sekretion af pepsin og saltsyre